Coral Laboratories Intrinsic Value
Coral Laboratories (CORALAB) median intrinsic value is ₹586.99 from 9 valuation models (range ₹375–₹1045), vs current price ₹614.50 — -4.5% downside (Trading Near Calculated Value), margin of safety -4.7%. Read CORALAB ex-dividend dates for the complete payout history and dividend yield track record.
CORALAB Valuation Methods Summary — DCF, Graham Number & P/E
Coral Laboratories intrinsic value across 9 models vs current price ₹614.50 — upside/downside and value range per method. Analyse CORALAB promoter holding to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1008.70 | ₹806.96 - ₹1210.44 | +64.1% | EPS: ₹45.85, Sector P/E: 22x |
| Book Value Method | asset | ₹1045.00 | ₹940.50 - ₹1149.50 | +70.1% | Book Value/Share: ₹522.50, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹430.00 | ₹387.00 - ₹473.00 | -30.0% | Revenue/Share: ₹215.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹375.00 | ₹337.50 - ₹412.50 | -39.0% | EBITDA: ₹15.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹441.46 | ₹353.17 - ₹529.75 | -28.2% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹586.99 | ₹528.29 - ₹645.69 | -4.5% | EPS Growth: 16.0%, Fair P/E: 12.8x |
| Growth Adjusted P/E | growth | ₹694.02 | ₹624.62 - ₹763.42 | +12.9% | Revenue Growth: 1.8%, Adj P/E: 15.1x |
| ROE Based Valuation | profitability | ₹425.00 | ₹382.50 - ₹467.50 | -30.8% | ROE: 8.1%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹734.18 | ₹660.76 - ₹807.60 | +19.5% | EPS: ₹45.85, BVPS: ₹522.50 |
CORALAB Intrinsic Value vs Market Price — All Valuation Models
Coral Laboratories fair value range ₹375–₹1045 vs current market price ₹614.50 across 9 valuation models. For current market price and key ratios, visit Coral Laboratories stock price NSE.
CORALAB Intrinsic Value Analysis — Undervalued or Overvalued?
Coral Laboratories median intrinsic value ₹586.99, current price ₹614.50 — Trading Near Calculated Value by 4.5%, margin of safety -4.7%.
What is the intrinsic value of CORALAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Coral Laboratories (CORALAB) is ₹586.99 (median value). With the current market price of ₹614.50, this represents a -4.5% variance from our estimated fair value.
The valuation range spans from ₹375.00 to ₹1045.00, indicating ₹375.00 - ₹1045.00.
Is CORALAB undervalued or overvalued?
Based on our multi-method analysis, Coral Laboratories (CORALAB) appears to be trading near calculated value by approximately 4.5%.
CORALAB Financial Health — Key Ratios vs Industry Benchmarks
Coral Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 44.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.1% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.36x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
CORALAB Cash Flow Quality — Operating & Free Cash Flow
Coral Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-6 Cr | ₹-6 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹13 Cr | ₹12 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |